封面
市場調查報告書
商品編碼
1386121

貓疫苗市場報告:2030 年趨勢、預測與競爭分析

Cat Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

貓疫苗趨勢和預測

預計到 2030 年,全球貓疫苗市場將達到 17 億美元,2024 年至 2030 年複合年成長率為 7.2%。這個市場的主要促進因素是養貓數量的增加以及對預防貓傳染病的疫苗接種的強烈需求。全球貓疫苗市場前景廣闊,獸醫院、寵物店、線上零售通路蘊藏商機。

貓疫苗市場洞察

Lucintel 預測,減毒活病毒疫苗將繼續成為最大的區隔市場,因為它們效率高,並且能夠支持抗體和細胞介導的免疫反應。

在這個市場中,預計獸醫院將在預測期內實現最高成長。

由於政府對保護貓免受嚴重疾病的疫苗接種的嚴格規定以及美國貓擁有量的增加,北美將繼續成為最大的地區。

市場規模/估計:以金額的貓疫苗市場規模估計(10 億美元)。

趨勢和預測分析:各個區隔市場和地區的市場趨勢(2018-2023)和預測(2024-2030)。

區隔分析:依技術、年齡、配銷通路和地區分類的貓疫苗市場規模(十億美元)。

區域分析:北美、歐洲、亞太地區和世界其他地區的貓疫苗市場區隔。

成長機會:依技術、年齡、配銷通路和地區對貓疫苗市場進行成長機會分析。

策略分析:貓疫苗市場併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析。

本報告回答了 11 個關鍵問題:

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼?
  • Q.2.哪個區隔市場將以更快的速度成長?為什麼?
  • Q.3.哪些地區未來會出現更快的成長?為什麼?
  • Q.4. 影響市場動態的主要因素有哪些?市場的主要課題和商業風險是什麼?
  • Q.5. 這個市場的商業風險和競爭威脅是什麼?
  • Q.6.這個市場有哪些新趨勢?為什麼?
  • Q.7.市場客戶需求有何改變?
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位?
  • Q.9.這個市場的主要企業有哪些?主要企業採取哪些策略配合措施來發展業務?
  • Q.10. 該市場上的競爭產品有哪些?由於材料或產品替代而導致市場佔有率下降的威脅有多大?
  • Q.11.過去五年發生了哪些併購事件,對產業產生了哪些影響?

目錄

第1章執行摘要

第2章全球貓疫苗市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球貓疫苗市場趨勢(2018-2023)與預測(2024-2030)
  • 依技術分類的全球貓疫苗市場
    • 減毒活病毒疫苗
    • 結合疫苗
    • 去活化疫苗
    • 次單位疫苗
    • 類毒素疫苗
    • DNA疫苗
    • 重組疫苗
  • 依年齡分類的全球貓疫苗市場
    • 少於6個月
    • 6個月或以上
  • 依配銷通路分類的全球貓疫苗市場
    • 動物醫院
    • 寵物商店
    • 線上零售商

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球貓疫苗市場區域分佈
  • 北美貓疫苗市場
  • 歐洲貓疫苗市場
  • 亞太貓疫苗市場
  • 其他地區貓疫苗市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球貓疫苗市場成長機會(依技術)
    • 依年齡分類的全球貓疫苗市場成長機會
    • 全球貓疫苗市場成長機會(依配銷通路)
    • 全球貓疫苗市場成長機會(依地區)
  • 全球貓疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球貓疫苗市場產能擴張
    • 全球貓疫苗市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Elanco Animal Health
  • Boehringer Ingelheim
  • Merck
  • Zoetis
  • Bioveta
簡介目錄

Cat Vaccine Trends and Forecast

The future of the global cat vaccine market looks promising with opportunities in the veterinary clinic, pet store, and online retailer channels. The global cat vaccine market is expected to reach an estimated $1.7 billion by 2030 with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are rising cat ownership and significant demand for vaccinations to prevent cat-transmitted diseases.

A more than 150-page report is developed to help in your business decisions.

Cat Vaccine by Segment

The study includes a forecast for the global cat vaccine by technology, age, distribution channel, and region.

Cat Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

Cat Vaccine Market by Age [Shipment Analysis by Value from 2018 to 2030]:

  • Below 6 Months
  • Above 6 Months

Cat Vaccine Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Veterinary Clinics
  • Pet Stores
  • Online Retailers

Cat Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cat Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cat vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cat vaccine companies profiled in this report include-

  • Elanco Animal Health
  • Boehringer Ingelheim
  • Merck
  • Zoetis
  • Bioveta

Cat Vaccine Market Insights

Lucintel forecasts that attenuated live will remain the largest segment due to its high efficiency and helps for both antibody and cellular immune responses.

Within this market, veterinary clinics is expected to witness highest growth over the forecast period.

North America will remain the largest region due to strict government regulations regarding vaccination in protecting the cats from serious diseases and rising adoption of cats in the USA.

Features of the Global Cat Vaccine Market

Market Size Estimates: Cat vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cat vaccine market size by technology, age, distribution channel, and region in terms of value ($B).

Regional Analysis: Cat vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, ages, distribution channels, and regions for the cat vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cat vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cat vaccine market size?

Answer: The global cat vaccine market is expected to reach an estimated $1.7 billion by 2030.

Q.2 What is the growth forecast for cat vaccine market?

Answer: The global cat vaccine market is expected to grow with a CAGR of 7.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cat vaccine market?

Answer: The major drivers for this market are rising cat ownership and significant demand for vaccinations to prevent cat-transmitted diseases.

Q4. What are the major segments for cat vaccine market?

Answer: The future of the cat vaccine market looks promising with opportunities in the veterinary clinic, pet store, and online retailer channels.

Q5. Who are the key cat vaccine market companies?

Answer: Some of the key cat vaccine companies are as follows:

  • Elanco Animal Health
  • Boehringer Ingelheim
  • Merck
  • Zoetis
  • Bioveta

Q6. Which cat vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that attenuated live will remain the largest segment due to its high efficiency and helps for both antibody and cellular immune responses.

Q7. In cat vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to strict government regulations regarding vaccination in protecting the cats from serious diseases and rising adoption of cats in the USA.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cat vaccine market by technology (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines), age (below 6 months and above 6 months), distribution channel (veterinary clinics, pet stores, and online retailers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cat Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cat Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cat Vaccine Market by Technology
    • 3.3.1: Attenuated Live Vaccines
    • 3.3.2: Conjugate Vaccines
    • 3.3.3: Inactivated Vaccines
    • 3.3.4: Subunit Vaccines
    • 3.3.5: Toxoid Vaccines
    • 3.3.6: DNA Vaccines
    • 3.3.7: Recombinant Vaccines
  • 3.4: Global Cat Vaccine Market by Age
    • 3.4.1: Below 6 Months
    • 3.4.2: Above 6 Months
  • 3.5: Global Cat Vaccine Market by Distribution Channel
    • 3.5.1: Veterinary Clinics
    • 3.5.2: Pet Stores
    • 3.5.3: Online Retailers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cat Vaccine Market by Region
  • 4.2: North American Cat Vaccine Market
    • 4.2.2: North American Cat Vaccine Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
  • 4.3: European Cat Vaccine Market
    • 4.3.1: European Cat Vaccine Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
    • 4.3.2: European Cat Vaccine Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
  • 4.4: APAC Cat Vaccine Market
    • 4.4.1: APAC Cat Vaccine Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
    • 4.4.2: APAC Cat Vaccine Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
  • 4.5: ROW Cat Vaccine Market
    • 4.5.1: ROW Cat Vaccine Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
    • 4.5.2: ROW Cat Vaccine Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cat Vaccine Market by Technology
    • 6.1.2: Growth Opportunities for the Global Cat Vaccine Market by Age
    • 6.1.3: Growth Opportunities for the Global Cat Vaccine Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Cat Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Cat Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cat Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cat Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Elanco Animal Health
  • 7.2: Boehringer Ingelheim
  • 7.3: Merck
  • 7.4: Zoetis
  • 7.5: Bioveta